A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal menopause research and awareness efforts over five years. The legislation would ...
The Federal Trade Commission has extended its antitrust review of Novo Holdings’ $16.5 billion purchase of Catalent by potentially another 30 days as it requests additional information. Both the ...
The Senate Finance Committee released a bipartisan draft legislation on Friday morning that would give Medicare bonuses to healthcare providers that help fight generic drug shortages. “It is ...
Updated data from a trial of Johnson & Johnson’s experimental “pretzel” showed that more than 80% of bladder cancer patients who got the treatment saw their tumors melt away, building ...
The House Committee on Oversight will mark up a far-reaching bill on May 15 that, if passed, could force many US biopharma companies to cut ties with WuXi and several other Chinese life ...
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The fight to dominate the market for weight loss shots has never been hotter, but drugmakers ...
AEON Biopharma said its botulinum toxin treatment candidate failed a Phase 2 migraine study at the planned interim analysis. The company ...